Verified Supplier#149759N7MTRFA575RSSponsored
Retatrutide
GLP-1 Peptide · 5mg~60mg
MOQ: 10 vials / 1 kit
Wholesale Pricing$48 - $480Supplier marketplace pricing range
Purity99.576%
Tested11 MAY 2026
Supplier Rating★ 4.9
Orders629
Verified supplierChina
LLY BioGlobal peptide supplier focused on research-grade peptides, custom synthesis, OEM peptide manufacturing, and reliable worldwide fulfilment through integrated manufacturing and export supply networks.
FedExUPSDHLRoyal Mail
Supplier listing intelligence
Retatrutide wholesale supplier listing
Product overview
Wholesale Retatrutide peptide supply from LLY Bio with public Janoshik verification, free worldwide shipping, configurable 5mg to 60mg vial options, OEM manufacturing support, and global research peptide fulfilment.
Purity99.576%
MOQ10 vials / 1 kit
MG Range5mg~60mg
SupplierLLY Bio
Supplier details
LLY Bio
CountryChina
Task Number#149759
Verification KeyN7MTRFA575RS
Tested11 MAY 2026
Global fulfilment
Shipping lanes
Tracking information is provided after dispatch and updated throughout international transit.
FedEx / UPS Express Shipping5–9 business daysFree shipping
Royal Mail / DHL Express5–10 business daysFree shipping
DHL / UPS Europe Shipping6–12 business daysFree shipping
Asia-Pacific Priority Shipping5–10 business daysFree shipping
More from this seller
More products from LLY Bio
Browse additional verified listings from the same marketplace supplier.
Compound intelligence
Retatrutide
Overview
Retatrutide is an investigational synthetic peptide designed as a triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptor pathways. It is one of the most closely watched metabolic research compounds because it combines three incretin and energy-balance signalling pathways in a single molecule.
Molecular Class
Synthetic peptide / incretin-based triple hormone receptor agonist.
Mechanism
Retatrutide is designed to activate glucose-dependent insulinotropic polypeptide receptor, glucagon-like peptide-1 receptor, and glucagon receptor pathways. This combined receptor profile makes it different from single GLP-1 agonists and dual GIP/GLP-1 agonists.
Research Areas
- Obesity research
- Metabolic signalling research
- Type 2 diabetes research
- Liver-fat and MASLD research
- Appetite and satiety pathway research
- Cardiovascular risk-factor research
- Energy expenditure research
- Incretin pharmacology research
Research Status
Retatrutide remains an investigational compound in active clinical development. Lilly is studying it across several Phase 3 programs, including obesity, type 2 diabetes, sleep apnea, osteoarthritis, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease.
Market Demand
Global demand is driven by obesity, metabolic disease, GLP-1, and next-generation incretin research. China-based peptide manufacturers frequently list retatrutide in wholesale vial formats for international research buyers.
Product FAQ
Retatrutide supplier questions
What is Retatrutide?
Retatrutide is a glp-1 peptide supplied by LLY Bio, featuring public Janoshik-linked batch testing references, 5mg~60mg vial configurations, and China fulfilment support for research-use laboratory workflows.
What MG configurations are available for Retatrutide?
Retatrutide is available in 5mg~60mg configurations depending on LLY Bio inventory availability and supplier stock levels.
Has Retatrutide undergone batch testing?
LLY Bio is a peptide supplier operating from China, offering Retatrutide batches with public laboratory testing references and international fulfilment support.
Who supplies this Retatrutide?
LLY Bio is a China-based peptide supplier offering Retatrutide batches with public laboratory testing references and international fulfilment support.
What is the MOQ for Retatrutide?
The current minimum order quantity for Retatrutide is 10 vials / 1 kit.
Is Retatrutide intended for human use?
Retatrutide is supplied strictly for laboratory research use only and is not sold for human consumption, medical use, or self-administration.